Sanchez, Kate B.

HRN: 29-19-82  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
07/28/2026
CLINDAMYCIN 150MG/ML, 4ML (AMP)
07/28/2026
07/29/2026
IV
900mg
Q8
Sp 1 LTCS
Remove - Pending Acceptance
07/28/2026
GENTAMICIN 40MG/ML, 2ML (AMP)
07/28/2026
07/30/2026
IV
240 Mg
Loading Dose
Sp 1 LTCS
Remove - Pending Acceptance
07/28/2026
CLINDAMYCIN 300MG (CAP)
07/30/2026
08/05/2026
PO
300 Mg
TID
Sp 1 LTCS
Remove - Pending Acceptance
07/28/2026
MUPIROCIN 2%, 15G (TUBE)
07/30/2026
08/03/2026
DERMAL
2%
OD
Sp 1 LTCS
Remove - Pending Acceptance

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: